The market size of the Global Biomedical Textiles Market in the year 2021 is valued at 13.51 billion and is predicted to reach 24.67 billion by the year 2030 at an 7.10% CAGR during the forecast period.
Fibrous textiles, called biomedical textiles, are used for biological and medical purposes. The biocompatibility textiles are used in surgeries, first aid, and to keep a space sterile. To function properly, such fabrics must be biocompatible with biological tissues and fluids. The rise in the older population, increased healthcare spending, and high demand for biomedical textiles and sophisticated wound dressings are the main factors propelling market revenue development. In addition, biomedical textiles are frequently used to produce first-aid items like bandages and wound dressings because of their remarkable characteristics like filtration, lightness, and absorption.
Additionally, a significant element propelling the market's revenue growth over the anticipated period is the ongoing development of smart biomedical textiles and medical technology improvements. A growing number of techniques, particularly for less invasive surgical operations, are being developed due to the quick advancement of medical knowledge. Modern medical advances have used biomedical textiles to replace damaged tissues or organs. Orthopedic surgeons more frequently utilize non-woven non-woven fiber mats with Teflon and graphite to promote tissue formation around orthopedic implants. While these implants replace bones and joints, fixation plates stabilize fractured bones. It is anticipated that these elements will increase demand for biomedical textiles.
Market Segmentation:
The biomedical textiles market is segmented on fiber, fabric, and application. Based on fiber type, the market is segmented into non-biodegradable and biodegradable. Based on application, the biomedical textiles market is segmented into surgical sutures and non-implantable. Based on the fabric type, the biomedical textiles market is segmented into non-woven, non-woven and woven.
Based on fiber type, the non-woven segment is a major contributor to the biomedical textiles market.
The non-woven non-woven market is anticipated to increase steadily throughout the projected period. As they work to avoid cross-contamination and the spread of infection in a medical or surgical environment, the non-woven non-woven fabric offers essential safety qualities, including prevention against infections and diseases. Non-wovens-wovens are also increasingly employed in creating intelligent wound care solutions, including encouraging moist wound healing conditions, lowering skin adhesion, and regulating vapor transfer. Several biomedical textiles use non-woven non-woven fabrics, including sheets, tubes, gowns, face masks, scrub suits, shoe covers, head covers, sponges, wipes, and plugs. Non-woven-woven fabrics are frequently used in surgical dressings, bandages, and implant applications.
The non-biodegradable segment witnessed growth at a rapid rate.
The non-biodegradable market is anticipated to expand quickly throughout the forecast period. The production of biomedical textiles, intended to close open wounds and remove them once the wound has fully healed, is increasingly using non-biodegradable fibers, causing this segment's income to expand. Surgical sutures, bandages, extracorporeal devices, and soft and hard tissue implants treat wounds. Polypropylene, viscose, polyester, polyethylene, and polyamide are non-biodegradable fibers that prevent bacteria from colonizing sutures.
The North American biomedical textiles market holds a significant regional revenue share.
The North American market is anticipated to have the greatest revenue share in the global market due to an increase in home healthcare services. The rapid increase in elderly people and the demand for services to diagnose diabetes are anticipated to propel market revenue growth in this area over the forecast year. Besides, the Asia Pacific market to experience a very high rate of revenue growth over the upcoming years due to the rise in chronic wounds and surgical treatments is likely to cause. Additionally, rising healthcare spending and the swift expansion of the healthcare sector in developing nations like China and India fuel the market's revenue growth.
Competitive Landscape
Some major key players in the Biomedical Textiles market are Paul Hartmann (Germany), BSN Medical (Sweden), Royal DSM (Netherlands), Covidien (Ireland), Integra Life Sciences (US), Johnson & Johnson (US), Smith & Nephew (UK), Medline Industries (US), B.Braun Melsungen (Germany), and Cardinal Health (US).
By Application:
